Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EFL1P2 is a processed pseudogene that shares sequence similarity with the functional gene EFL1, a GTPase involved in ribosomal subunit maturation and protein synthesis[1][3][5]. However, EFL1P2 itself does not code for a functional protein, does not have known biological activity, and is not considered a therapeutic target or receptor[1][2][3]. Pseudogenes such as EFL1P2 may have sequence roles in genome evolution or gene regulation, but there is no evidence of a direct physiological or disease-related function for EFL1P2 specifically. Information relevant to EFL1P2 is limited primarily to its identification as a pseudogene on chromosome 4q13.1, with no documented role in disease, drug interaction, or biomarker utility[1][3]. The entry may be confused with true protein-coding elongation factors (EFL1, EFTUD1, EFTUD2) that are involved in essential cellular machinery[2][4][5]. Any query involving EFL1P2 as a receptor, enzyme, or drug target is incorrect based on current genomic annotations and functional understanding[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Elongation factor like GTPase 1 pseudogene 2 (EFL1P2).